These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 25679134

  • 1. Inositol-deficient food augments a behavioral effect of long-term lithium treatment mediated by inositol monophosphatase inhibition: an animal model with relevance for bipolar disorder.
    Shtein L, Agam G, Belmaker RH, Bersudsky Y.
    J Clin Psychopharmacol; 2015 Apr; 35(2):175-7. PubMed ID: 25679134
    [Abstract] [Full Text] [Related]

  • 2. Lithium-pilocarpine seizures as a model for lithium action in mania.
    Belmaker RH, Bersudsky Y.
    Neurosci Biobehav Rev; 2007 Apr; 31(6):843-9. PubMed ID: 17602744
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Knockout mice in understanding the mechanism of action of lithium.
    Agam G, Bersudsky Y, Berry GT, Moechars D, Lavi-Avnon Y, Belmaker RH.
    Biochem Soc Trans; 2009 Oct; 37(Pt 5):1121-5. PubMed ID: 19754464
    [Abstract] [Full Text] [Related]

  • 5. The inositol monophosphatase inhibitor L-690,330 affects pilocarpine-behavior and the forced swim test.
    Shtein L, Toker L, Bersudsky Y, Belmaker RH, Agam G.
    Psychopharmacology (Berl); 2013 Jun; 227(3):503-8. PubMed ID: 23344554
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. IMPA1 is essential for embryonic development and lithium-like pilocarpine sensitivity.
    Cryns K, Shamir A, Van Acker N, Levi I, Daneels G, Goris I, Bouwknecht JA, Andries L, Kass S, Agam G, Belmaker H, Bersudsky Y, Steckler T, Moechars D.
    Neuropsychopharmacology; 2008 Feb; 33(3):674-84. PubMed ID: 17460611
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inositol deficiency diet and lithium effects.
    Shaldubina A, Stahl Z, Furszpan M, Regenold WT, Shapiro J, Belmaker RH, Bersudsky Y.
    Bipolar Disord; 2006 Apr; 8(2):152-9. PubMed ID: 16542185
    [Abstract] [Full Text] [Related]

  • 11. Effects of the putative lithium mimetic ebselen on pilocarpine-induced neural activity.
    Singh N, Serres F, Toker L, Sade Y, Blackburn V, Batra AS, Saiardi A, Agam G, Belmaker RH, Sharp T, Vasudevan SR, Churchill GC.
    Eur J Pharmacol; 2020 Sep 15; 883():173377. PubMed ID: 32687920
    [Abstract] [Full Text] [Related]

  • 12. Inositol monophosphatase--a putative target for Li+ in the treatment of bipolar disorder.
    Atack JR, Broughton HB, Pollack SJ.
    Trends Neurosci; 1995 Aug 15; 18(8):343-9. PubMed ID: 7482796
    [Abstract] [Full Text] [Related]

  • 13. Increased inositol-monophosphatase activity by lithium treatment in bipolar patients.
    Kaya N, Resmi H, Ozerdem A, Guner G, Tunca Z.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May 15; 28(3):521-7. PubMed ID: 15093960
    [Abstract] [Full Text] [Related]

  • 14. High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy.
    Gill R, Mohammed F, Badyal R, Coates L, Erskine P, Thompson D, Cooper J, Gore M, Wood S.
    Acta Crystallogr D Biol Crystallogr; 2005 May 15; 61(Pt 5):545-55. PubMed ID: 15858264
    [Abstract] [Full Text] [Related]

  • 15. Myo-inositol-1-phosphate (MIP) synthase inhibition: in-vivo study in rats.
    Einat H, Tian F, Belmaker RH, Frost JW.
    J Neural Transm (Vienna); 2008 May 15; 115(1):55-8. PubMed ID: 17828434
    [Abstract] [Full Text] [Related]

  • 16. Behavioral reversal of lithium effects by four inositol isomers correlates perfectly with biochemical effects on the PI cycle: depletion by chronic lithium of brain inositol is specific to hypothalamus, and inositol levels may be abnormal in postmortem brain from bipolar patients.
    Belmaker RH, Agam G, van Calker D, Richards MH, Kofman O.
    Neuropsychopharmacology; 1998 Sep 15; 19(3):220-32. PubMed ID: 9653710
    [Abstract] [Full Text] [Related]

  • 17. Behavioral analyses of transgenic mice harboring bipolar disorder candidate genes, IMPA1 and IMPA2.
    Ohnishi T, Watanabe A, Ohba H, Iwayama Y, Maekawa M, Yoshikawa T.
    Neurosci Res; 2010 May 15; 67(1):86-94. PubMed ID: 20153384
    [Abstract] [Full Text] [Related]

  • 18. Regional changes in rat brain inositol monophosphatase 1 (IMPase 1) activity with chronic lithium treatment.
    Parthasarathy LK, Seelan RS, Wilson MA, Vadnal RE, Parthasarathy RN.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb 15; 27(1):55-60. PubMed ID: 12551726
    [Abstract] [Full Text] [Related]

  • 19. Lack of lithium-like behavioral and molecular effects in IMPA2 knockout mice.
    Cryns K, Shamir A, Shapiro J, Daneels G, Goris I, Van Craenendonck H, Straetemans R, Belmaker RH, Agam G, Moechars D, Steckler T.
    Neuropsychopharmacology; 2007 Apr 15; 32(4):881-91. PubMed ID: 16841073
    [Abstract] [Full Text] [Related]

  • 20. Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate.
    Vadnal R, Parthasarathy R.
    Neuropsychopharmacology; 1995 Jul 15; 12(4):277-85. PubMed ID: 7576004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.